Showing 1 - 9 results of 9 for search 'Francis J. Giles', query time: 0.04s Refine Results
  1. 1
    Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances CD8+ T cell cytolytic killing of melanoma cells

    Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances... by Gary Shaw, Ludimila Cavalcante, Francis J. Giles, Alison Taylor

    Published 2022-09-01
    Get full text
    Article
  2. 2
    Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance

    Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance by Jennifer S Carew, Steffan T Nawrocki, Francis J Giles, John L Cleveland

    Published 2008-06-01
    Get full text
    Article
  3. 3
    Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms

    Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms by Jason B. Kaplan, Brady L. Stein, Brandon McMahon, Francis J. Giles, Leonidas C. Platanias

    Published 2016-01-01
    Get full text
    Article
  4. 4
    9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer

    9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer by Hiroo Kuroki, Tsutomu Anraku, Akira Kazama, Vladimir Bilim, Masayuki Tasaki, Daniel Schmitt, Andrew P. Mazar, Francis J Giles, Andrey Ugolkov, Yoshihiko Tomita

    Published 2019-12-01
    Get full text
    Article
  5. 5
    ELR510444 inhibits tumor growth and angiogenesis by abrogating HIF activity and disrupting microtubules in renal cell carcinoma.

    ELR510444 inhibits tumor growth and angiogenesis by abrogating HIF activity and disrupting microtubules in renal cell carcinoma. by Jennifer S Carew, Juan A Esquivel, Claudia M Espitia, Christoph M Schultes, Marcel Mülbaier, Joe D Lewis, Bernd Janssen, Francis J Giles, Steffan T Nawrocki

    Published 2012-01-01
    Get full text
    Article
  6. 6
    FGFR3–TACC3: A novel gene fusion in cervical cancer

    FGFR3–TACC3: A novel gene fusion in cervical cancer by Benedito A. Carneiro, Julia A. Elvin, Suneel D. Kamath, Siraj M. Ali, Ajit S. Paintal, Alvaro Restrepo, Emily Berry, Francis J. Giles, Melissa L. Johnson

    Published 2015-08-01
    Get full text
    Article
  7. 7
    Clinical cardiac safety profile of nilotinib

    Clinical cardiac safety profile of nilotinib by Theo D. Kim, Philipp le Coutre, Michaela Schwarz, Peggy Grille, Michal Levitin, Suzanne Fateh-Moghadam, Francis J. Giles, Bernd Dörken, Wilhelm Haverkamp, Clemens Köhncke

    Published 2012-06-01
    Get full text
    Article
  8. 8
    Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma

    Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma by Andrew Hsu, Kelsey E. Huntington, Andre De Souza, Lanlan Zhou, Adam J. Olszewski, Nirav P. Makwana, Diana O. Treaba, Ludimila Cavalcante, Francis J. Giles, Howard Safran, Wafik S. El-Deiry, Benedito A. Carneiro

    Published 2022-12-01
    Get full text
    Article
  9. 9
    The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer

    The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer by Yuqian Yan, Jian Ma, Dejie Wang, Dong Lin, Xiaodong Pang, Shangqian Wang, Yu Zhao, Lei Shi, Hui Xue, Yunqian Pan, Jun Zhang, Claes Wahlestedt, Francis J Giles, Yu Chen, Martin E Gleave, Collin C Collins, Dingwei Ye, Yuzhuo Wang, Haojie Huang

    Published 2019-09-01
    Get full text
    Article

Search Tools: